SEC Tracker
Get the app

Immunovant IMVT

Immunovant: additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
Document
DEFA14A

Not explained yet; the original is on EDGAR.

Additional proxy materials

View on EDGAR

Open in the app

Get an email when Immunovant files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Innoviva INVA public float $1.3B, Jun 30, 2025
  2. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  3. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025
  4. Travere Therapeutics TVTX public float $1.3B, Jun 30, 2025
  5. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.